Ipratropium Bromide Solution
Product Images NDC 64980-640

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 64980-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

97e130d5-figure-01 (97e130d5 Figure 01)

FDA Label Image

97e10d5-figure-02 (97e130d5 Figure 02)

FDA Label Image

97e130d5-figure-03 (97e130d5 Figure 03)

FDA Label Image

97e130d5-figure-04 (97e130d5 Figure 04)

FDA Label Image

F05 (Screenshot 2025 03 07 140115)

This is a description of Ipratropium Bromide Inhalation Solution, USP 0.02%, with a concentration of 0.5 mg/2.5 mL. Each low-density polyethylene vial contains 25 ml of the solution. The medication is intended for oral inhalation only and should not be injected. The solution is preserved with an isotonic saline solution and should be stored between 15°C and 30°C (59°F and 86°F). The dosage instructions should be followed as per the prescribing information provided. The solution is sterile and comes in 5 packs of 25mL unit dose vials. Pharmacists are instructed to detach the patient instructions from the package insert and dispense the solution accordingly.*

FDA Label Image

Figure 06 (Screenshot 2025 03 07 141620)

This is the description: "Ipratropium Bromide Inhalation Solution, USP 0.02%, 0.5 mg/2.5 ml for oral inhalation only. Not for nebulization. The text also includes a CAD File number: 12508."*

FDA Label Image

Figure 07 (Screenshot 2025 03 07 142042)

This is a description of Ipratropium Bromide Inhalation Solution, USP 0.02%, with a recommended dosage of 0.5 mg per 25 mL for oral inhalation use only. It emphasizes not to use this solution for injection and provides some details on administration.*

FDA Label Image

Figure 08 (Screenshot 2025 03 07 142840)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.